AstraZeneca saw its China sales growth slow down in the first quarter, when the coronavirus outbreak was at […]
Category: Uncategorized
Moderna Therapeutics has partnered with the federal government to create an mRNA-based COVID-19 vaccine it hopes to speed […]
At the J.P. Morgan Healthcare Conference in January—back when few could predict the looming destruction of COVID-19—Amgen CEO […]
Gilead Sciences scored a massive win earlier this week with its first positive data readout for investigational candidate […]
AbbVie may be working through COVID-19, but it’s pressing ahead with its Allergan merger, too—and taking stock of products […]
Antiviral drug remdesivir helps patients hospitalised with covid-19 recover faster and may also reduce mortality, according to the […]
The recommendations bring closer to approval new therapies for asthma, acute myeloid leukaemia, transfusion-dependent anaemia, diabetes, prostate cancer, […]
It is expected that the move will allow the EMA to complete its assessment of the drug significantly […]
NICE is sharing its work with initiatives such as the WHO’s Evidence Collaborative for COVID-19
ATTRACT (Angiotensin II Type Two Receptor Agonist Covid-19 Trial) is targeting hospitalised patients treated with basic respiratory care, […]